NCT04782908

Brief Summary

The aim of the study is to investigate the pathophysiological implications of transcatheter tricuspid valve edge-to-edge repair in patient with heart failure and preserved ejection fraction and severe tricuspid regurgitation. Changes in right- and left-ventricular function as well as the interventricular dependence will be analysed on a multimodal basis including pressure-volume loop analysis and cardiac magnetic resonance imaging.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

April 19, 2021

Status Verified

April 1, 2021

Enrollment Period

1.1 years

First QC Date

March 1, 2021

Last Update Submit

April 14, 2021

Conditions

Keywords

Heart failure with preserved ejection fractiontricuspid regurgitationtranscatheter tricuspid valve edge-to-edge repair

Outcome Measures

Primary Outcomes (1)

  • Periprocedural change in enddiastolic pressure volume relationship of the left ventricle

    Change in the ratio of pressure to volume of the left ventricle before and after TTVR. Measurement will take place during TTVR with patient in general anesthesia. Measures will be made using a commercially available conductance catheter. Data analysis will be performed offline using a dedicated software.

    Periprocedural.

Secondary Outcomes (4)

  • Change in the estimated left ventricular end diastolic volume at 10 mmHg as estimated by the left ventricular pressure volume relationship (LVEDPVR)

    Periprocedural.

  • Change in the ratio of isovolumetric relaxation constant "Tau" and duration of diastole of the left ventricle.

    Periprocedural.

  • Change in dPdtmin

    Periprocedural.

  • Change in the early diastolic filling pattern as assessed by MRI.

    Baseline and 1-month follow-up following TTVR.

Study Arms (1)

Transcatheter tricuspid valve edge-to-edge repair

EXPERIMENTAL

Patients will undergo transcatheter tricuspid valve edge-to-edge repair (TTVR) and hemodynamic characteristics will be analysed on a multimodal approach using cardiac magnetic resonance imaging and pressure volume loop analysis before and after TTVR.

Device: Transcatheter tricuspid valve edge-to-edge repair

Interventions

Transcatheter tricuspid valve edge-to-edge repair is an interventional approach to treat severe tricuspid regurgitation. Under general anesthesia a clip delivery system is forwarded through the vena femoralis and right atrium in the right ventricle. A clip is deployed to clamp the tricuspid valve and reduce tricuspid valve regurgitation.

Transcatheter tricuspid valve edge-to-edge repair

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Severe tricuspid regurgitation with need for interventional treatment approach as decided by an interdisciplinary heart team.
  • Signs and symptoms of left-sided heart failure.
  • Left-ventricular ejection fraction ≥50%
  • Invasive evidence of elevated left-ventricular fillings pressures (pulmonary capillary wedge pressure \[PCWP\] or left-ventricular end-diastolic pressure ≥15 mmHg)

You may not qualify if:

  • Concomitant relevant mitral valve regurgitation with need for concomitant interventional treatment
  • Moderate aortic stenosis.
  • Pregnancy
  • Contraindication to perform cardiac magnetic resonance imaging.
  • Conditions rendering patient unable to give informed consent to the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Centre at University Leipzig

Leipzig, Saxony, 04289, Germany

RECRUITING

MeSH Terms

Conditions

Heart FailureTricuspid Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesHeart Valve Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Outcome assessors will be blinded whether they are analysing pre or post transcatheter tricuspid valve edge-to-edge repair data.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Patients undergoing transcatheter tricuspid valve edge-to-edge repair will undergo multimodal cardiovascular diagnostics before and after tricuspid valve repair including pressure volume loop analysis and cardiac magnetic resonance imaging
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Managing Senior Physician

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 4, 2021

Study Start

March 1, 2021

Primary Completion

March 30, 2022

Study Completion

June 30, 2022

Last Updated

April 19, 2021

Record last verified: 2021-04

Locations